An interventional study of Chatbot group and website assisted in Health Behaviors, Artificial Intelligence (AI) and Chatbot, sponsored by Gaziantep Islam Science and Technology University. Completed at 1 site in Turkey. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-05.
Sponsored by Gaziantep Islam Science and Technology University · Not applicable, Interventional, and Prevention
The aim of this project is to evaluate the effectiveness of using chatbots for patient education about dry eye disease. The study will examine how the chatbot affects patients' levels of information, managing symptoms, and overall satisfaction.
967 studies on the registry are indexed under Health Behavior; 165 are open to participants now.
This study's enrollment of 63 is below the median of 150 across 824 interventional studies indexed under Health Behavior.
Browse Health Behavior studies →Gaziantep Islam Science and Technology University is the lead sponsor of 43 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants explored these topics using the website.
Other: website assisted
Participants explored the topics using the AI chatbot platform
Other: Chatbot group
Participants explored the topics using the AI chatbot platform.
Participants explored the topics using the website platform
Dry Eye and eye strain knowledge questionnaire
Time frame: From enrollment to the end of training at 4 weeks
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Gaziantep Islam Science and Technology University